UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 60

Sortiert nach

An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy

European journal of cancer (1990), 2012-02, Vol.48 (3), p.324-332

2012

Link zum Volltext

Verfügbarkeit prüfen

Induction chemotherapy with docetaxel and cisplatin is highly effective for locally advanced nasopharyngeal carcinoma

Oral oncology, 2011-07, Vol.47 (7), p.660-664

2011

Link zum Volltext

Verfügbarkeit prüfen

Successful use of docetaxel for emergency treatment of disseminated intravascular coagulation due to hormone-refractory metastatic prostate cancer

Journal of oncological science, 2017-07, Vol.3 (2), p.81-83

2017

Link zum Volltext

Verfügbarkeit prüfen

Response Rates and Adverse Effects of Continuous Once-daily Sunitinib in Patients with Advanced Renal Cell Carcinoma: A Single-center Study in Turkey

Japanese journal of clinical oncology, 2011-12, Vol.41 (12), p.1380-1387

2011

Link zum Volltext

Verfügbarkeit prüfen

The First Case of Primary Testicular Germ Cell Tumor Containing Nephroblastoma as the Only One Non-germ Cell Component

Japanese journal of clinical oncology, 2011-08, Vol.41 (8), p.1037-1040

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma

Journal of clinical oncology, 2014-09, Vol.32 (25), p.2765-2772

2014

Link zum Volltext

Verfügbarkeit prüfen

How to approach castration-resistant prostate cancer?

Marmara Medical Journal, 2015-01, Vol.28 (4), p.24

BAVBEK, Sevil

2015

Link zum Volltext

Verfügbarkeit prüfen

MP11-07 RADIOLIGAND THERAPY WITH 177 Lu-PSMA-I&T IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: ONCOLOGICAL OUTCOMES AND TOXICITY PROFILE

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Link zum Volltext

Verfügbarkeit prüfen

PD16-04 DIFFERENTIAL TREATMENT RESPONSE OF PROSTATE AND METASTATIC LESIONS IN PATIENTS WITH NEWLY DIAGNOSED METASTATIC PROSTATE CANCER

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Link zum Volltext

Verfügbarkeit prüfen

Differential treatment response of prostate and metastatic lesions in patients with newly diagnosed metastatic prostate cancer

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.56-56

2023

Link zum Volltext

Verfügbarkeit prüfen

Timing of death from tumor recurrence after curative gastrectomy for gastric cancer

American journal of clinical oncology, 2004-04, Vol.27 (2), p.205-209

2004

Link zum Volltext

Verfügbarkeit prüfen

Ewing's Sarcoma of the Axial System in Patients Older Than 15 Years: Dismal Prognosis Despite Intensive Multiagent Chemotherapy and Aggressive Local Treatment

Japanese journal of clinical oncology, 2004-11, Vol.34 (11), p.667-672

2004

Link zum Volltext

Verfügbarkeit prüfen

Prostate-specific Membrane Antigen Positron Emission Tomography as a Biomarker to Assess Treatment Response in Patients with Advanced Prostate Cancer

European urology focus, 2023-07, Vol.9 (4), p.596-605

2023

Link zum Volltext

Verfügbarkeit prüfen

Beyond traditional therapies: clinical significance of complex molecular profiling in patients with advanced solid tumours-results from a Turkish multi-centre study

Japanese journal of clinical oncology, 2024-05, Vol.54 (5), p.562-568

2024

Link zum Volltext

Verfügbarkeit prüfen

Induction chemotherapy (IC) followed by concurrent chemoradiotherapy (CCRT) in nasopharyngeal carcinoma(NPC) patients treated between 2004 and 2016: Patient and treatment characteristics and long term outcome

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e17507-e17507

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical Outcome of Rhabdomyosarcoma in Adolescent and Adult Patients: Single Center Experience from Turkey

The Tohoku Journal of Experimental Medicine, 2007, Vol.213(3), pp.221-229

2007

Link zum Volltext

Verfügbarkeit prüfen

CD44 variant exons in leukemia and lymphoma

Pathology oncology research, 2002, Vol.8 (1), p.36-40

2002

Link zum Volltext

Verfügbarkeit prüfen

Proceedings From the 5th B2B Uro-Oncology: GU Cancers Triad Meeting: Prostate Cancer

Société internationale d'urologie journal, 2023-11, Vol.4 (Suppl 2)

2023

Link zum Volltext

Verfügbarkeit prüfen

A Phase II Study of Cisplatin, Ifosfamide and Epirubicin Combination Chemotherapy in Adults with Nonmetastatic and Extremity Osteosarcomas

Oncology, 2007-01, Vol.72 (3-4), p.255-260

2007

Link zum Volltext

Verfügbarkeit prüfen

Renal cell cancer: overview of the current therapeutic landscape

Expert review of anticancer therapy, 2016-09, Vol.16 (9), p.955-968

2016

Link zum Volltext

Verfügbarkeit prüfen

EFFECT OF AGE ON CHARACTERISTICS AND CLINICAL BEHAVIOR OF ADULT AGRESSIVE NON-HODGKIN'S LYMPHOMA

European journal of general medicine, 2006-11, Vol.3 (3), p.93

Suleyman Alici, Sevil E. Bavbek, Mert Basaran, Haluk Onat

2006

Link zum Volltext

Verfügbarkeit prüfen

Predictive value of marker half-life in relapsed and nonrelapsed nonseminomatous germ cell testicular tumor patients undergoing chemotherapy

American journal of clinical oncology, 2012-08, Vol.35 (4), p.369-372

2012

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors in localized aggressive non-Hodgkin's lymphoma

American journal of clinical oncology, 2003-02, Vol.26 (1), p.1-5

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(57)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(38)
Science & Technology
(38)
Humans
(33)
Male
(29)
Oncology
(29)
Female
(26)
Adult
(24)
Middle Aged
(23)
Aged
(21)
Adolescent
(16)
Retrospective Studies
(14)
Treatment Outcome
(14)
Prognosis
(11)
Aged, 80 And Over
(10)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Neoplasm Staging
(10)
Survival Analysis
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Young Adult
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial

An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy

Induction chemotherapy with docetaxel and cisplatin is highly effective for locally advanced nasopharyngeal carcinoma

Successful use of docetaxel for emergency treatment of disseminated intravascular coagulation due to hormone-refractory metastatic prostate cancer

Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial

Response Rates and Adverse Effects of Continuous Once-daily Sunitinib in Patients with Advanced Renal Cell Carcinoma: A Single-center Study in Turkey

The First Case of Primary Testicular Germ Cell Tumor Containing Nephroblastoma as the Only One Non-germ Cell Component

Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma

How to approach castration-resistant prostate cancer?

MP11-07 RADIOLIGAND THERAPY WITH 177 Lu-PSMA-I&T IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: ONCOLOGICAL OUTCOMES AND TOXICITY PROFILE

PD16-04 DIFFERENTIAL TREATMENT RESPONSE OF PROSTATE AND METASTATIC LESIONS IN PATIENTS WITH NEWLY DIAGNOSED METASTATIC PROSTATE CANCER

Differential treatment response of prostate and metastatic lesions in patients with newly diagnosed metastatic prostate cancer

Timing of death from tumor recurrence after curative gastrectomy for gastric cancer

Ewing's Sarcoma of the Axial System in Patients Older Than 15 Years: Dismal Prognosis Despite Intensive Multiagent Chemotherapy and Aggressive Local Treatment

Prostate-specific Membrane Antigen Positron Emission Tomography as a Biomarker to Assess Treatment Response in Patients with Advanced Prostate Cancer

Beyond traditional therapies: clinical significance of complex molecular profiling in patients with advanced solid tumours-results from a Turkish multi-centre study

Induction chemotherapy (IC) followed by concurrent chemoradiotherapy (CCRT) in nasopharyngeal carcinoma(NPC) patients treated between 2004 and 2016: Patient and treatment characteristics and long term outcome

Clinical Outcome of Rhabdomyosarcoma in Adolescent and Adult Patients: Single Center Experience from Turkey

CD44 variant exons in leukemia and lymphoma

Proceedings From the 5th B2B Uro-Oncology: GU Cancers Triad Meeting: Prostate Cancer

A Phase II Study of Cisplatin, Ifosfamide and Epirubicin Combination Chemotherapy in Adults with Nonmetastatic and Extremity Osteosarcomas

Renal cell cancer: overview of the current therapeutic landscape

EFFECT OF AGE ON CHARACTERISTICS AND CLINICAL BEHAVIOR OF ADULT AGRESSIVE NON-HODGKIN'S LYMPHOMA

Predictive value of marker half-life in relapsed and nonrelapsed nonseminomatous germ cell testicular tumor patients undergoing chemotherapy

Prognostic factors in localized aggressive non-Hodgkin's lymphoma

Suchergebnisse filtern